Gilles Guillon - Concepedia

Author

Gilles Guillon

Also Known As

G GUILLON, G Guillon, G. Guillon, GILLES GUILLON, Gaëlle Guillon, Gilles GUILLON, Gilles Guillon, Guillon Gilles, Guillon, G., Guillon, Gilles

192

Publications

6.8K

Citations

H-Index

128

Concepts

All Affiliations

Inserm Centre National de la Recherche Scientifique Université de Montpellier Université de Sherbrooke Institut de Génomique Fonctionnelle

About

Gilles Guillon is an author at Inserm specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	74	3.5K
2	Natural Sciences	15	21	617
3	Public Health	5	5	651
4	Health Sciences	3	3	104
5	Engineering	1	1	13

Gilles Guillon

117

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of oxytocin receptor function by direct binding of progesterone Eric Grazzini, Gilles Guillon, Bernard Mouillac, Nature Hormonal ContraceptiveMedicineHormonal ReceptorPhysiologyPharmacology	1998	468
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Serge Jard, Rolf C. Gaillard, Gilles Guillon, Molecular Pharmacology	1986	272
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. C. Serradeil‐Le Gal, C Lacour, G Valette, Journal of Clinical Investigation Molecular PharmacologySelective AffinityArginine VasopressinSr 121463AFunctional Selectivity	1996	247
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. A Enjalbert, Fritz Sladeczek, Gilles Guillon, Journal of Biological Chemistry Cellular PhysiologyGastrointestinal Peptide HormoneAnterior Pituitary CellsMolecular PharmacologyPituitary Gland	1986	244
Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand, Journal of Pharmacology and Experimental Therapeutics	2002	207
An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism Hamid Méziane, Fabienne Schaller, Š. Bauer, Biological Psychiatry Developmental BiologyDevelopmental Cognitive NeuroscienceAdult Mice DeficientGeneticsPrader-willi Syndrome	2014	185
Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Gilles Guillon, Miguel Trueba, Dominique Joubert, Endocrinology Human Adrenal GlandsExperimental PharmacologyCellular PhysiologyReproductive EndocrinologyAdrenal Gland	1995	125
Structural Requirements for Activation of Vasopressin-sensitive Adenylate Cyclase, Hormone Binding, and Antidiuretic Actions: Effects of Highly Potent Analogues and Competitive Inhibitors Daniel Butlen, Gilles Guillon, Rabary M. Rajerison, Molecular Pharmacology	1978	122
Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla. Eric Grazzini, A M Lodboerer, Antonia Pérez‐Martin, Endocrinology Social SciencesMolecular PharmacologyAdrenal GlandNeuroendocrine MechanismHypothalamic Peptide	1996	83
Conopressin-T from Conus tulipa Reveals an Antagonist Switch in Vasopressin-like Peptides Sébastien Dutertre, Daniel E. Croker, Norelle L. Daly, Journal of Biological Chemistry	2008	81

Page 1